Rabbit Polyclonal IL-34 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Recombinant Fragment Protein within Human IL34 aa 150 to C-terminus.
View Alternative Names
C16orf77, IL34, Interleukin-34, IL-34
- WB
Unknown
Western blot - Anti-IL-34 antibody (AB224734)
All lanes:
Western blot - Anti-IL-34 antibody (ab224734) at 1/500 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma cell line) whole cell lysate
Lane 2:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate
Secondary
All lanes:
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 27 kDa
Observed band size: 27 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-34 antibody (AB224734)
Paraffin-embedded human small intestine tissue stained for IL-34 with ab224734 at 1/100 dilution in immunohistochemical analysis.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 12:845765 PubMed35936748
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:639724 PubMed34336646
2021
Applications
Unspecified application
Species
Unspecified reactive species
European journal of immunology 51:2501-2512 PubMed34138470
2021
Applications
Unspecified application
Species
Unspecified reactive species
Virchows Archiv : an international journal of path 474:375-381 PubMed30580386
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com